http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2754434-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b86e50a7529f6158517db14a0b81df |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e687e80e16df4cc4a0f45452c0ef208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95036778b78ace3a497c4f4a0bffb60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3f42921ec6913a601f7278ed771eed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24bd22999b64b098a084169992991a82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a42b7947c5a88824c7bfa030827a17f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c0b7e186455ac0e06e03fe3e9fb9e8 |
| publicationDate | 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2754434-T3 |
| titleOfInvention | Prostate Cancer Prognosis Methods |
| abstract | A method comprising: - determining a level of gene expression for the distinctive genes: AZGP1, FBLN1, ILK, KRT15, MEIS2, MYBPC1, PAGE4, SRD5A2, COL1A1, COL3A1, COL5A2, INHBA, THBS2, VCAN, BGN, BIRC5 and DYRK2 and optionally PDE4 isoforms comprising PDE4D5 and / or PDE4D7, to obtain an expression profile of the subject for a subject, and further comprising: - classifying the subject as having a good prognosis or a poor prognosis of prostate cancer based on the subject's expression profile, in which the good prognosis predicts a greater probability of survival within a predetermined period of time after the initial diagnosis and / or no progression of the disease after primary treatment, and the poor prognosis predicts an aggressive disease, a lower probability of survival and a greater probability of biochemical recurrence, clinical recurrence and / or the presence of local or distant metastases, within a pred period of time terminated after initial diagnosis; and / or - classify the subject as having or not having a predisposition for prostate cancer that is susceptible to the progression of the disease based on the expression profile of the subject, in which the predisposition predicts an aggressive disease, less probability of Survival and increased likelihood of biochemical recurrence, clinical recurrence, and / or the presence of local or distant metastases, within a predetermined period of time after initial diagnosis. |
| priorityDate | 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 628.